The board of directors of CVS Health Corporation (NYSE:CVS) declared on Thursday its quarterly dividend of USD0.50 per share on its common stock.
This dividend is due on 1 November 2018 to shareholders of record as of 24 October 2018.
According to the pharmacy company, it enables people, businesses and communities to manage health in more affordable and effective ways through its integrated model.
Through retail locations and walk-in medical clinics, the pharmacy company serves 1m patients per year, with a stand-alone Medicare Part D prescription drug plan.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development